Effects of OKY-046, a Selective Thromboxane A2 Synthetase Inhibitor, on Ventricular Arrhythmias and Prostaglandins during Coronary Artery Ligation and Reperfusion in Anesthetized Dogs

摘要

References(9) Cited-By(2) Effects of OKY-046, a selective thromboxane synthetase inhibitor, on ischemia-induced ventricular arrhythmias were investigated in anesthetized dogs. OKY-046 (30 mg/kg, intravenously) decreased ventricular arrhythmias significantly both during 30 min of coronary artery ligation and subsequent reperfusion, which corresponded with a significant reduction of thromboxane concentration, suggesting that thromboxane released during ligation is an important factor in the development of ventricular arrhythmias. Inhibition of thromboxane synthesis with OKY-046 might be useful for the prevention of ischemia-induced ventricular arrhythmias.